Ads
related to: cmml 2 leukemia- Treatment Considerations
Learn How Adverse Events May Impact
Reaching CML Treatment Goals.
- TKI Daily Life Impact
Learn About Adherence In CML
And The Impact Of Adverse Events.
- Informative CML Videos
Watch Videos About Important Topics
In CML From Experts And Patients.
- Importance Of TKI Choice
Discover How Time On A TKI
May Affect Outcomes In CML.
- Treatment Considerations
Search results
Results From The WOW.Com Content Network
Chronic myelomonocytic leukemia (CMML) is a type of leukemia, which are cancers of the blood-forming cells of the bone marrow. In adults, blood cells are formed in the bone marrow, by a process that is known as haematopoiesis .
It has been said that acute myeloid leukemia can occur from a progression of chronic myelomonocytic leukemia type 1 and 2. [7] Normal red blood cells decrease and a rapid proliferation of the abnormal myeloblasts occur. [2] Apoptosis functional ability decreases which causes a back up of myeloblasts in the bone marrow and blood. [2]
Chronic myelomonocytic leukemia (CMML), not to be confused with chronic myelogenous leukemia or CML characterized by less than 20% myeloblasts in the bone marrow and greater than 1*10 9 /L monocytes (a type of white blood cell) circulating in the peripheral blood.
The American Cancer Society estimates that in 2014, about 5,980 new cases of chronic myeloid leukemia were diagnosed, and about 810 people died of the disease. This means that a little over 10% of all newly diagnosed leukemia cases will be chronic myeloid leukemia. The average risk of a person getting this disease is 1 in 588.
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. [1]
[1] [2] Because these tissues are all intimately connected through both the circulatory system and the immune system, a disease affecting one will often affect the others as well, making aplasia, myeloproliferation and lymphoproliferation (and thus the leukemias and the lymphomas) closely related and often overlapping problems.
Ads
related to: cmml 2 leukemia